- Previous Close
45.85 - Open
45.32 - Bid 46.87 x --
- Ask 46.88 x --
- Day's Range
45.32 - 46.97 - 52 Week Range
39.75 - 66.80 - Volume
1,962,659 - Avg. Volume
1,825,393 - Market Cap (intraday)
7.191B - Beta (5Y Monthly) --
- PE Ratio (TTM)
19.70 - EPS (TTM)
2.38 - Earnings Date --
- Forward Dividend & Yield 1.20 (2.56%)
- Ex-Dividend Date Apr 26, 2024
- 1y Target Est
--
Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells medicines in China. It offers medicines and pediatric drugs under the Jianmin, Longmu, and Yekaitai brand name. The company provides OTC, medical, and general health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. was founded in 1993 and is headquartered in Wuhan, China.
www.whjm.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 600976.SS
View MorePerformance Overview: 600976.SS
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600976.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600976.SS
View MoreValuation Measures
Market Cap
7.19B
Enterprise Value
6.25B
Trailing P/E
19.70
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.04
Price/Book (mrq)
2.95
Enterprise Value/Revenue
1.78
Enterprise Value/EBITDA
13.99
Financial Highlights
Profitability and Income Statement
Profit Margin
10.33%
Return on Assets (ttm)
2.98%
Return on Equity (ttm)
15.63%
Revenue (ttm)
3.5B
Net Income Avi to Common (ttm)
362.18M
Diluted EPS (ttm)
2.38
Balance Sheet and Cash Flow
Total Cash (mrq)
1.12B
Total Debt/Equity (mrq)
7.17%
Levered Free Cash Flow (ttm)
183.86M